OctoPlus enters into drug development and manufacturing contract with Ferring Pharmaceuticals A/S
Click here to access the webcast of 29 July 2011
'OctoPlus is dedicated to the creation of dosage forms for biotech derived and small molecules for optimal pharmacotherapy.'
